Hydrocortisone for Asthma
Hydrocortisone is not the preferred corticosteroid for asthma management—inhaled corticosteroids are the mainstay for long-term control, while oral prednisone/prednisolone (not hydrocortisone) is recommended for acute exacerbations. 1
Long-Term Asthma Control
Inhaled corticosteroids (ICS) are the most consistently effective long-term control medication at all steps of care for persistent asthma, superior to any other single medication including leukotriene receptor antagonists. 1 They reduce airway hyperresponsiveness, inhibit inflammatory cell migration and activation, and block late-phase allergic reactions. 1
Dosing Strategy by Severity
- Mild persistent asthma (Step 2): Low-dose inhaled corticosteroids as preferred therapy 1
- Moderate persistent asthma (Step 3-4): Low to medium-dose ICS plus long-acting beta-agonist (LABA) as preferred combination 1
- Severe persistent asthma (Step 5-6): High-dose ICS plus LABA, with oral systemic corticosteroids added if needed 1
Critical safety point: Long-acting beta-agonists must never be used as monotherapy—they are only used in combination with ICS, as monotherapy increases exacerbations and mortality risk. 1
Acute Exacerbations
Oral systemic corticosteroids (prednisone, prednisolone, or methylprednisolone) are recommended for moderate to severe asthma exacerbations, not hydrocortisone. 1
Specific Dosing for Acute Exacerbations
- Adults: 40-80 mg/day prednisone in 1 or 2 divided doses until PEF reaches 70% of predicted or personal best 1
- Children: 1-2 mg/kg/day (maximum 60 mg/day) in 2 divided doses until PEF is 70% of predicted 1
- Outpatient burst: 40-60 mg prednisone daily for 5-10 days in adults; 1-2 mg/kg/day (max 60 mg/day) for 3-10 days in children 1
When Hydrocortisone Is Used (Intravenous Route)
If intravenous administration is required (severe exacerbations where oral route is compromised), low-dose hydrocortisone is as effective as high doses. 2, 3
- Effective IV dose: Hydrocortisone 50 mg every 6 hours (200 mg/day total) for 48 hours, then transition to oral prednisone 2
- Higher doses provide no additional benefit: Studies comparing 200 mg/day vs 500 mg/day vs 2000 mg/day hydrocortisone found no differences in FEV1 improvement, symptom resolution, or clinical outcomes 2, 3
- Equivalency: 20 mg hydrocortisone = 5 mg prednisolone 4
Important caveat: Single doses of hydrocortisone do not produce immediate benefits in acute asthma—corticosteroids require sustained administration over 24-48 hours to demonstrate clinical effect. 5
No Advantage for IV Over Oral Route
There is no known advantage for intravenous corticosteroid administration over oral therapy, provided gastrointestinal transit time or absorption is not impaired. 1 Oral prednisone should be used unless the patient is vomiting or has impaired consciousness.
Duration and Tapering
- Short courses (≤1 week): No taper needed 1
- Courses up to 10 days: Probably no taper needed, especially if patient is concurrently taking ICS 1
- Long-term therapy discontinuation: Withdraw gradually rather than abruptly 4
Monitoring Requirements
Increasing use of short-acting beta-agonists (more than 2 days per week or more than 2 nights per month) indicates inadequate asthma control and need to initiate or intensify anti-inflammatory therapy. 1 Using more than one canister of short-acting beta-agonist per month signals need for treatment escalation. 1
Side Effects Consideration
The dose-response curve for corticosteroids is relatively flat beyond moderate doses—high doses provide minimal additional benefit but substantially increase systemic side effects including adrenal suppression, bone loss, glucose intolerance, and immunosuppression. 6, 7 This supports using the lowest effective dose.